STRATA Financial Statements From 2010 to 2024

SSKN Stock  USD 2.94  0.11  3.61%   
STRATA Skin financial statements provide useful quarterly and yearly information to potential STRATA Skin Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on STRATA Skin financial statements helps investors assess STRATA Skin's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting STRATA Skin's valuation are summarized below:
Gross Profit
19.9 M
Profit Margin
(0.25)
Market Capitalization
12.7 M
Enterprise Value Revenue
0.6775
Revenue
32.7 M
We have found one hundred twenty available fundamental trend indicators for STRATA Skin Sciences, which can be analyzed and compared to other ratios and to its competition. Self-guided Investors are advised to double-check STRATA Skin's current fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself for the next two years. As of the 26th of November 2024, Market Cap is likely to drop to about 18.3 M. In addition to that, Enterprise Value is likely to drop to about 23.3 M

STRATA Skin Total Revenue

19.5 Million

Check STRATA Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among STRATA Skin's main balance sheet or income statement drivers, such as Total Revenue of 19.5 M, Gross Profit of 11.1 M or Other Operating Expenses of 22.8 M, as well as many indicators such as Price To Sales Ratio of 0.55, Dividend Yield of 0.0 or PTB Ratio of 1.59. STRATA financial statements analysis is a perfect complement when working with STRATA Skin Valuation or Volatility modules.
  
Check out the analysis of STRATA Skin Correlation against competitors.

STRATA Skin Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets30.1 M42 M35.5 M
Slightly volatile
Non Current Assets Total27.8 M26.5 M20.2 M
Slightly volatile
Common Stock Shares OutstandingM3.5 M5.9 M
Pretty Stable
Liabilities And Stockholders Equity30.1 M42 M35.5 M
Slightly volatile
Total Current Assets17.2 M15.5 M16.3 M
Slightly volatile
Other Stockholder Equity157.6 M250.7 M204.5 M
Slightly volatile
Non Currrent Assets Other304.8 K231 K363.9 K
Pretty Stable
Other Current Assets1.1 M1.6 M1.3 M
Slightly volatile
Total Liabilities30.8 M29.3 M17.9 M
Slightly volatile
Short and Long Term Debt Total11.9 M15.6 M9.9 M
Slightly volatile
Total Current Liabilities6.2 M12.2 M7.6 M
Slightly volatile
Cash10.1 M6.8 M9.4 M
Very volatile
Cash And Short Term Investments10.4 M6.8 M9.4 M
Very volatile
Property Plant And Equipment Net13 M12.4 MM
Slightly volatile
Current Deferred RevenueM2.1 M1.2 M
Slightly volatile
Accounts Payable2.5 M3.3 M2.9 M
Slightly volatile
Other Assets301.5 K248.4 K333.3 K
Pretty Stable
Net Receivables2.6 M4.4 M2.4 M
Slightly volatile
Common Stock Total Equity22.1 K39.1 K24.4 K
Slightly volatile
Non Current Liabilities Total9.9 M17.2 M9.7 M
Slightly volatile
Property Plant And Equipment Gross38.5 M36.7 M10.3 M
Slightly volatile
Short Term Debt668.8 K704 K1.4 M
Pretty Stable
Intangible Assets5.6 M7.3 M7.1 M
Slightly volatile
Common Stock24.5 K40.2 K24.7 K
Slightly volatile
Property Plant Equipment4.7 M8.6 M6.1 M
Slightly volatile
Other Liabilities1.1 M765.9 K943.2 K
Very volatile
Capital Surpluse235.9 M281.6 M218.7 M
Slightly volatile
Long Term Debt Total897.8 K945 K5.8 M
Slightly volatile
Short and Long Term Debt5.3 M7.9 M6.4 M
Pretty Stable
Non Current Liabilities Other1.7 M1.7 M995.4 K
Slightly volatile
Net Invested Capital26.6 M27.7 M32.6 M
Slightly volatile
Net Working Capital5.1 M3.4 M4.7 M
Slightly volatile
Capital Stock37.2 K40.2 K32.9 K
Slightly volatile
Capital Lease Obligations757.4 K589 K1.2 M
Slightly volatile

STRATA Skin Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses22.8 M39.7 M28.1 M
Slightly volatile
Research Development1.3 M1.3 M2.4 M
Slightly volatile
Total Operating Expenses17 M24.8 M19.4 M
Slightly volatile
Depreciation And Amortization6.2 M5.9 M3.9 M
Slightly volatile
Selling General Administrative8.9 M10.5 M9.5 M
Very volatile
Non Recurring808.8 K909.9 K990.8 K
Slightly volatile
Selling And Marketing Expenses11.9 M13 M8.9 M
Slightly volatile
Preferred Stock And Other Adjustments2.7 M3.4 M2.6 M
Slightly volatile
Interest Income182.4 K192 K3.6 M
Slightly volatile
Reconciled Depreciation4.1 MM5.6 M
Slightly volatile

STRATA Skin Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation6.2 M5.9 M3.9 M
Slightly volatile
Capital Expenditures5.3 MM2.7 M
Slightly volatile
End Period Cash Flow10.5 M8.1 M10.1 M
Very volatile
Begin Period Cash Flow10.1 M6.8 M10.7 M
Pretty Stable
Stock Based Compensation1.2 M1.3 M30.2 M
Slightly volatile
Issuance Of Capital Stock13.6 M15.3 M16.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.550.5758306
Slightly volatile
Days Sales Outstanding72.6448.582189.1299
Slightly volatile
Book Value Per Share3.453.633450.799
Slightly volatile
Average Payables467.2 K795.4 K802.4 K
Pretty Stable
Stock Based Compensation To Revenue0.03710.03911.288
Slightly volatile
Capex To Depreciation0.810.85040.9934
Pretty Stable
Inventory Turnover5.855.57313.3925
Slightly volatile
Days Of Inventory On Hand62.2265.4927147
Slightly volatile
Payables Turnover3.524.45623.8994
Slightly volatile
Sales General And Administrative To Revenue0.30.31513.1206
Slightly volatile
Average Inventory27.9 K31.4 K34.2 K
Slightly volatile
Research And Ddevelopement To Revenue0.03750.03954.1059
Slightly volatile
Capex To Revenue0.140.15055.1365
Slightly volatile
Cash Per Share1.851.942720.9572
Slightly volatile
Days Payables Outstanding11681.9088137
Slightly volatile
Intangibles To Total Assets0.350.32940.2795
Slightly volatile
Current Ratio1.211.27673.1656
Slightly volatile
Receivables Turnover5.827.51316.4085
Slightly volatile
Graham Number15.1315.923234
Slightly volatile
Debt To Equity0.721.21340.5891
Pretty Stable
Capex Per Share1.371.43737.459
Slightly volatile
Revenue Per Share9.079.552640.2159
Very volatile
Interest Debt Per Share4.634.878542.737
Pretty Stable
Debt To Assets0.30.36640.264
Pretty Stable
Operating Cycle108114235
Slightly volatile
Days Of Payables Outstanding11681.9088137
Slightly volatile
Ebt Per Ebit1.211.269494.4112
Slightly volatile
Long Term Debt To Capitalization0.360.54250.3
Very volatile
Total Debt To Capitalization0.390.54820.3363
Very volatile
Debt Equity Ratio0.721.21340.5891
Pretty Stable
Quick Ratio1.01.05722.7363
Slightly volatile
Net Income Per E B T0.630.99160.9492
Pretty Stable
Cash Ratio0.530.55732.2753
Slightly volatile
Cash Conversion Cycle30.5632.166101
Pretty Stable
Days Of Inventory Outstanding62.2265.4927147
Slightly volatile
Days Of Sales Outstanding72.6448.582189.1299
Slightly volatile
Fixed Asset Turnover2.272.68932.4251
Slightly volatile
Debt Ratio0.30.36640.264
Pretty Stable
Price Sales Ratio0.550.5758306
Slightly volatile
Asset Turnover0.830.79390.4552
Slightly volatile

STRATA Skin Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap18.3 M19.2 M22.5 M
Slightly volatile
Enterprise Value23.3 M28.1 M30.5 M
Pretty Stable

STRATA Fundamental Market Drivers

Cash And Short Term Investments6.8 M

STRATA Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About STRATA Skin Financial Statements

STRATA Skin investors utilize fundamental indicators, such as revenue or net income, to predict how STRATA Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.1 MM
Total Revenue33.4 M19.5 M
Cost Of Revenue14.9 M10.5 M
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 0.32  0.30 
Research And Ddevelopement To Revenue 0.04  0.04 
Capex To Revenue 0.15  0.14 
Revenue Per Share 9.55  9.07 
Ebit Per Revenue(0.26)(0.27)

Pair Trading with STRATA Skin

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STRATA Skin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATA Skin will appreciate offsetting losses from the drop in the long position's value.

Moving against STRATA Stock

  0.63CVS CVS Health Corp Aggressive PushPairCorr
  0.36PHG Koninklijke PhilipsPairCorr
  0.33FIGS Figs IncPairCorr
The ability to find closely correlated positions to STRATA Skin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STRATA Skin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STRATA Skin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STRATA Skin Sciences to buy it.
The correlation of STRATA Skin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STRATA Skin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STRATA Skin Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STRATA Skin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether STRATA Skin Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STRATA Skin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Strata Skin Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Strata Skin Sciences Stock:
Check out the analysis of STRATA Skin Correlation against competitors.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.60)
Revenue Per Share
9.347
Quarterly Revenue Growth
0.022
Return On Assets
(0.07)
Return On Equity
(0.63)
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.